Medication Adherence With Polyglot Meducation
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators propose a 6 month pre-post, pilot,feasibility study with up to 25 individuals among veterans with cardiovascular disease risk factors including Hypertension (HT), Diabetes Mellitis (DM) and Hyperlipidemia (HL) who receive care from the hospital-based primary care clinics associated with Durham VAMC. The investigators will examine veteran's perception and ease of using an innovative tool to help improve medication adherence to cardiovascular medications. This study aims to focus on patients with multiple chronic conditions and their caregivers to address 1) appropriate use of medications 2)maximize patient self-care and care by families and other caregivers 3) make available a tool for medication management 4) managing complex regimens, and 5) addressing health literacy.
| Condition | Intervention |
|---|---|
|
Hypertension Diabetes Hypercholesterolemia |
Behavioral: education intervention |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Health Services Research |
| Official Title: | Evaluate Changes in Medication Adherence and Patient Perspective of Polyglot Systems, Inc's Meducation Technology |
- medication adherence [ Time Frame: 6 months ] [ Designated as safety issue: No ]The primary outcome will be change in self reported medication adherence and pill refill adherence.
| Estimated Enrollment: | 25 |
| Study Start Date: | February 2013 |
| Estimated Study Completion Date: | September 2013 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: education intervention
The intervention provides a personalized Meducation calendar to all patients enrolled in the study (identified in package as Example Calendar). The Meducation Calendar will include medications for diabetes (sugar), high blood pressure, cholesterol, heart medications and blood thinning medications. The medication calendars contains the following for each medication 1) the name, 2) the time of day, including a pictorial display, it should be taken 3) the number of times each day to take the medication, and 4) the indication for the medication.
|
Behavioral: education intervention
Each patient will receive instructions on how to use the medication calendar to help them adhere to their medication regimen. The Meducation Calendar is developed by the clinical pharmacist participating in the research study). The clinical pharmacist will enter the medication regimen for each participant into the application for Meducation Calendar Development.
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Enrolled in one of three DVAMC Primary Care Clinics affiliated with the hospital for at least one year;
- At least one visit to a primary care provider (PCP) at Durham VAMC associated primary care clinics in the previous 12 months;
- Outpatient diagnostic code for hypertension (> 140/90), diabetes and/or hypercholesterolemia
- Prescription for metoprolol tartrate (twice a day beta blocker, most common 2 day medication prescribed in the VA)
- Baseline Medication Possession Ratio (MPR) of < 80% indicating medication non adherence
- More than 9 active medications.
Exclusion Criteria:
- diagnosed with metastatic cancer,
- diagnosed with dementia documented in medical record,
- active diagnosis of psychosis documented in medical record with admission with last 30 days
- participating in another clinical trial,
- not currently receiving care at the Durham VAMC
- resident of a nursing home,
- hard time seeing type/printing on books, magazines articles, etc.
- hard time hearing or speaking on the telephone
- limited/no access to telephone
- currently a patient in the primary care pharmacist medication management clinic at Durham VAMC
- plans to move medical care from DVAMC in next 12 months
Contacts and Locations| United States, North Carolina | |
| Durham VA Medical Center | |
| Durham, North Carolina, United States, 27701 | |
| Principal Investigator: | Hayden B Bosworth, PhD | Durham VA Medical Center |
More Information
No publications provided
| Responsible Party: | Durham VA Medical Center |
| ClinicalTrials.gov Identifier: | NCT01744392 History of Changes |
| Other Study ID Numbers: | 01658 |
| Study First Received: | December 5, 2012 |
| Last Updated: | February 25, 2013 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
Hypercholesterolemia Hypertension Hyperlipidemias Dyslipidemias |
Lipid Metabolism Disorders Metabolic Diseases Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 19, 2013